Compare · MDLN vs UTMD
MDLN vs UTMD
Side-by-side comparison of Medline Inc. (MDLN) and Utah Medical Products Inc. (UTMD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and UTMD operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $50.91B, about 238.1x UTMD ($213.8M).
- Over the past year, MDLN is down 4.8% and UTMD is up 15.6% - UTMD leads by 20.5 points.
- MDLN has been more active in the news (4 items in the past 4 weeks vs 2 for UTMD).
- MDLN has more recent analyst coverage (25 ratings vs 0 for UTMD).
- Company
- Medline Inc.
- Utah Medical Products Inc.
- Price
- $38.78+3.02%
- $67.37+4.61%
- Market cap
- $50.91B
- $213.8M
- 1M return
- +7.57%
- -4.07%
- 1Y return
- -4.83%
- +15.62%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- News (4w)
- 4
- 2
- Recent ratings
- 25
- 0
Utah Medical Products Inc.
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS endoscopic irrigation devices; suprapubic catheterization; LIBERTY urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN tool to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices through direct customer service and sales force, independent consultants, and manufacturer representatives. The company was incorporated in 1978 and is headquartered in Midvale, Utah.
Latest MDLN
- Medline strengthens California distribution network with new 1 million-square-foot facility in Perris
- Medline Inc. filed SEC Form 8-K: Leadership Update
- Medline announces Prime Vendor agreement with Allina Health
- Securing new 1.6-plus million square feet of new space after fire, Medline leases two large distribution centers in Northern California
- Medline to report second quarter 2026 results on August 5, 2026
- Officer Abrams William J covered exercise/tax liability with 1,308 shares, decreasing direct ownership by 7% to 16,546 units (SEC Form 4)
- Chief Human Resources Officer Shryock Christopher P covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)
- Chief Operating Officer Miller Stephen L covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)
- Chief Legal Officer Liberman Alexander M. covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)
- Chief Product Officer Laabs Amanda H. covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)
Latest UTMD
- Utah Medical Products Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2026
- Director Richins Paul O gifted 150 shares (SEC Form 4)
- Principal Financial Officer Koopman Brian gifted 50 shares, decreasing direct ownership by 6% to 782 units (SEC Form 4)
- SEC Form SD filed by Utah Medical Products Inc.
- SEC Form 10-Q filed by Utah Medical Products Inc.
- Utah Medical Products, Inc. Announces Quarterly Dividend
- Utah Medical Products Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Utah Medical Products Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2026